- Home
- BGLC vs AYRO Comparison
BGLC vs AYRO Comparison
Compare BGLC & AYRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGLC
- AYRO
- Stock Information
- Founded
- BGLC 2017
- AYRO 2017
- Country
- BGLC Malaysia
- AYRO United States
- Employees
- BGLC N/A
- AYRO N/A
- Industry
- BGLC Medical Specialities
- AYRO Telecommunications Equipment
- Sector
- BGLC Health Care
- AYRO Consumer Discretionary
- Exchange
- BGLC Nasdaq
- AYRO Nasdaq
- Market Cap
- BGLC 5.8M
- AYRO 4.8M
- IPO Year
- BGLC N/A
- AYRO N/A
- Fundamental
- Price
- BGLC $0.38
- AYRO $0.70
- Analyst Decision
- BGLC
- AYRO
- Analyst Count
- BGLC 0
- AYRO 0
- Target Price
- BGLC N/A
- AYRO N/A
- AVG Volume (30 Days)
- BGLC 10.9M
- AYRO 193.8K
- Earning Date
- BGLC 02-20-2025
- AYRO 11-14-2024
- Dividend Yield
- BGLC N/A
- AYRO N/A
- EPS Growth
- BGLC N/A
- AYRO N/A
- EPS
- BGLC N/A
- AYRO N/A
- Revenue
- BGLC $9,259,858.00
- AYRO $221,671.00
- Revenue This Year
- BGLC N/A
- AYRO $2,424.87
- Revenue Next Year
- BGLC N/A
- AYRO N/A
- P/E Ratio
- BGLC N/A
- AYRO N/A
- Revenue Growth
- BGLC N/A
- AYRO N/A
- 52 Week Low
- BGLC $0.21
- AYRO $0.64
- 52 Week High
- BGLC $3.39
- AYRO $1.86
- Technical
- Relative Strength Index (RSI)
- BGLC 59.27
- AYRO 47.30
- Support Level
- BGLC $0.33
- AYRO $0.64
- Resistance Level
- BGLC $0.41
- AYRO $0.72
- Average True Range (ATR)
- BGLC 0.11
- AYRO 0.06
- MACD
- BGLC 0.01
- AYRO -0.00
- Stochastic Oscillator
- BGLC 23.68
- AYRO 44.71
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.
About AYRO AYRO Inc.
AYRO Inc design and manufacture compact, sustainable electric vehicles for closed campus mobility, low-speed urban and community transport, local on-demand and last-mile delivery, and government use. It operates as one reportable segment, which is the design, development, manufacturing, and sales of electric vehicles, and operates in the United States.